Status:
COMPLETED
Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy
Lead Sponsor:
Nantes University Hospital
Conditions:
Amaurosis
Retinal Diseases
Eligibility:
All Genders
Phase:
NA
Brief Summary
Retinal dystrophies are responsible for numerous cases of blindness, and there are no therapeutic possibilities today. Gene therapy is efficient in a dog model concerning dystrophy linked to a mutatio...
Eligibility Criteria
Inclusion
- Patients with clinical characteristics of amaurosis of Leber
- Patients suffering from an early severe retinal dystrophy
- Patients with social insurance
- Patients with a consent form signed
Exclusion
- Retinal dystrophy with autosomal dominant transmission
- Retinal dystrophy occuring after 5 years of age
- Syndromical retinal dystrophy with one or more systemic manifestations
- Familial macular degeneration
- Familial choroid dystrophy
- Non-degenerative retinopathology
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT00422721
Start Date
April 1 2007
Last Update
November 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France, 44093